Latest News and Press Releases
Want to stay updated on the latest news?
-
* { font-family: Arial, Verdana, Helvetica; font-size: 13px;} td { padding: 3px; } }As a result of higher production DNO International ASA delivered increased revenues and improved results from...
-
BJÖRN BORG AB INTERIM REPORT JANUARY - SEPTEMBER 2010 INCREASED SALES AND STRONG MARGINS JULY 1 - SEPTEMBER 30, 2010 • The Group's net sales increased by 10 percent to SEK 171.0 million (155.2)....
-
BJÖRN BORG AB DELÅRSRAPPORT JANUARI - SEPTEMBER 2010 ÖKAD OMSÄTTNING OCH STARKA MARGINALER 1 JULI - 30 SEPTEMBER 2010 • Koncernens nettoomsättning ökade med 10 procent till 171,0 MSEK (155,2),...
-
STADA Arzneimittel AG / Key word(s): Interim Report 11.11.2010 07:25 --------------------------------------------------------------------------- Important items at a glance - Group sales EUR...
-
Interim results from Phase III trial show ASA404 failed to meet primary endpoint of extending survival for the second-line treatment of non-small cell lung cancer Related impairment charges of...
-
Salcomp Plc Interim Report 11 November 2010 at 8:15 a.m. Finnish time Salcomp Plc Interim Report 1 January - 30 September 2010 NET SALES CONTINUED STRONG GROWTH,...
-
Celesio AG / Key word(s): Quarter Results 11.11.2010 07:00 --------------------------------------------------------------------------- Celesio confirms forecast following successful third quarter...
-
CAPE TOWN, South Africa, Nov. 11, 2010 (GLOBE NEWSWIRE) -- Representatives from the private sector, government, civil society, and other interests are gathering in Cape Town from Nov. 15-17 for the...
-
* Net asset value per share on 30 September 2010 amounted to EUR 11.42 (EUR 9.15). The total net asset value amounted to EUR 398m (EUR 325m), corresponding to an increase of 3.8% (11.2%)...
-
* Substansvärdet per aktie uppgick den 30 september 2010 till 11,42 EUR (9,15 EUR). Det totala substansvärdet uppgick till 398 MEUR (325 MEUR), vilket innebar en ökning med 3,8 % (11,2 %)...